SNGX Stock Analysis: Buy, Sell, or Hold?
SNGX - Soligenix, Inc. Common Stock
$0.46
0.02 (4.13%)
▲
5d:
-44.07%
30d:
+49.77%
90d:
-61.53%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When SNGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SNGX is down 44.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SNGX is down 44.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SNGX is currently trading at $0.46, which is considered fair relative to its 30-day fair value range of $0.27 to $0.67.
Technical Outlook: Technically, SNGX is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $1.13. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.75 (+294.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNGX is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $1.13. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.75 (+294.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.27 -
$0.67
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 294.8% below Wall St target ($1.75)
- WARNING: Recommendation downgraded due to -44.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.35
Resistance Level
$1.13
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.77
Wall Street Target
$1.75
(+294.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 08, 2026 11:46 AM ET
Data refreshes hourly during market hours. Next update: 12:46 PM
Data refreshes hourly during market hours. Next update: 12:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 57 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$253 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
